BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1730745)

  • 1. Biological activities of peptides and peptide analogues derived from common sequences present in thrombospondin, properdin, and malarial proteins.
    Tuszynski GP; Rothman VL; Deutch AH; Hamilton BK; Eyal J
    J Cell Biol; 1992 Jan; 116(1):209-17. PubMed ID: 1730745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The properdin-like type I repeats of human thrombospondin contain a cell attachment site.
    Prater CA; Plotkin J; Jaye D; Frazier WA
    J Cell Biol; 1991 Mar; 112(5):1031-40. PubMed ID: 1999454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human platelet glycoprotein IIIb binds to thrombospondin fragments bearing the C-terminal region, and/or the type I repeats (CSVTCG motif), but not to the N-terminal heparin-binding region.
    Catimel B; Leung L; el Ghissasi H; Mercier N; McGregor J
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):231-6. PubMed ID: 1376110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain.
    Tuszynski GP; Rothman VL; Papale M; Hamilton BK; Eyal J
    J Cell Biol; 1993 Jan; 120(2):513-21. PubMed ID: 8421063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction.
    Leung LL; Li WX; McGregor JL; Albrecht G; Howard RJ
    J Biol Chem; 1992 Sep; 267(25):18244-50. PubMed ID: 1381367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of platelet macroaggregate formation by a recombinant heparin-binding domain of human thrombospondin.
    Legrand C; Morandi V; Mendelovitz S; Shaked H; Hartman JR; Panet A
    Arterioscler Thromb; 1994 Nov; 14(11):1784-91. PubMed ID: 7947604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite.
    Robson KJ; Hall JR; Jennings MW; Harris TJ; Marsh K; Newbold CI; Tate VE; Weatherall DJ
    Nature; 1988 Sep; 335(6185):79-82. PubMed ID: 3045563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-adhesive motif in region II of malarial circumsporozoite protein.
    Rich KA; George FW; Law JL; Martin WJ
    Science; 1990 Sep; 249(4976):1574-7. PubMed ID: 2120774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity.
    Tolsma SS; Volpert OV; Good DJ; Frazier WA; Polverini PJ; Bouck N
    J Cell Biol; 1993 Jul; 122(2):497-511. PubMed ID: 7686555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombospondin peptides inhibit the secretion-dependent phase of platelet aggregation.
    Rabhi-Sabile S; Thibert V; Legrand C
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):237-40. PubMed ID: 8735828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1.
    Clezardin P; Lawler J; Amiral J; Quentin G; Delmas P
    Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):819-27. PubMed ID: 9032471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin binds to the surface of human osteosarcoma cells and mediates platelet-osteosarcoma cell interaction.
    Clezardin P; Serre CM; Trzeciak MC; Drouin J; Delmas PD
    Cancer Res; 1991 May; 51(10):2621-7. PubMed ID: 1708697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombospondin as a mediator of cancer cell adhesion in metastasis.
    Walz DA
    Cancer Metastasis Rev; 1992 Nov; 11(3-4):313-24. PubMed ID: 1384998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding.
    Asch AS; Silbiger S; Heimer E; Nachman RL
    Biochem Biophys Res Commun; 1992 Feb; 182(3):1208-17. PubMed ID: 1371676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombospondins: structure and regulation of expression.
    Bornstein P
    FASEB J; 1992 Nov; 6(14):3290-9. PubMed ID: 1426766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta.
    Schultz-Cherry S; Lawler J; Murphy-Ullrich JE
    J Biol Chem; 1994 Oct; 269(43):26783-8. PubMed ID: 7929414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1.
    Adams JC; Lawler J
    Mol Biol Cell; 1994 Apr; 5(4):423-37. PubMed ID: 7519904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human microvascular endothelial cells adhere to thrombospondin-1 via an RGD/CSVTCG domain independent mechanism.
    Chen ZS; Pohl J; Lawley TJ; Swerlick RA
    J Invest Dermatol; 1996 Feb; 106(2):215-20. PubMed ID: 8601718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial amino acid sequence of human thrombospondin as determined by analysis of cDNA clones: homology to malarial circumsporozoite proteins.
    Kobayashi S; Eden-McCutchan F; Framson P; Bornstein P
    Biochemistry; 1986 Dec; 25(26):8418-25. PubMed ID: 3030396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain.
    Asch AS; Liu I; Briccetti FM; Barnwell JW; Kwakye-Berko F; Dokun A; Goldberger J; Pernambuco M
    Science; 1993 Nov; 262(5138):1436-40. PubMed ID: 7504322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.